Xicai Wang

498 total citations
31 papers, 397 citations indexed

About

Xicai Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xicai Wang has authored 31 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xicai Wang's work include Cancer-related molecular mechanisms research (6 papers), Lung Cancer Treatments and Mutations (5 papers) and RNA modifications and cancer (5 papers). Xicai Wang is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Lung Cancer Treatments and Mutations (5 papers) and RNA modifications and cancer (5 papers). Xicai Wang collaborates with scholars based in China and Hong Kong. Xicai Wang's co-authors include Yongchun Zhou, Yunchao Huang, Guangqiang Zhao, Yujie Lei, Lianhua Ye, Shuguang Zuo, Xiaoqun Chen, Youguang Huang, Xin Liu and Qian Yao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Letters.

In The Last Decade

Xicai Wang

31 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xicai Wang China 13 238 142 82 67 46 31 397
Jia Luo China 10 252 1.1× 185 1.3× 54 0.7× 31 0.5× 31 0.7× 22 401
Mengnan He China 10 217 0.9× 63 0.4× 105 1.3× 94 1.4× 15 0.3× 20 372
Bakhyt Zhumabayeva Germany 9 334 1.4× 97 0.7× 61 0.7× 65 1.0× 12 0.3× 9 556
Colin A. Bill United States 10 261 1.1× 70 0.5× 91 1.1× 25 0.4× 35 0.8× 22 496
Elena Alexandrova Italy 17 455 1.9× 137 1.0× 95 1.2× 44 0.7× 49 1.1× 47 669
Taro Hihara Japan 9 350 1.5× 42 0.3× 30 0.4× 40 0.6× 24 0.5× 14 482
Magdalena Olbryt Poland 13 334 1.4× 168 1.2× 126 1.5× 84 1.3× 51 1.1× 25 1.2k

Countries citing papers authored by Xicai Wang

Since Specialization
Citations

This map shows the geographic impact of Xicai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xicai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xicai Wang more than expected).

Fields of papers citing papers by Xicai Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xicai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xicai Wang. The network helps show where Xicai Wang may publish in the future.

Co-authorship network of co-authors of Xicai Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xicai Wang. A scholar is included among the top collaborators of Xicai Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xicai Wang. Xicai Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhao, Guiping, Jiahong Sun, Xicai Wang, et al.. (2021). Serum Creatine Kinase as a Biomarker to Predict Wooden Breast in vivo for Chicken Breeding. Frontiers in Physiology. 12. 711711–711711. 17 indexed citations
3.
Tan, Xiaodong, Ranran Liu, Yonghong Zhang, et al.. (2021). Integrated analysis of the methylome and transcriptome of chickens with fatty liver hemorrhagic syndrome. BMC Genomics. 22(1). 8–8. 21 indexed citations
4.
Chen, Xiaobo, Ke Zhao, Dafu Zhang, et al.. (2019). <p>Nomogram For The Prediction Of Malignancy In Small (8–20 mm) Indeterminate Solid Solitary Pulmonary Nodules In Chinese Populations</p>. Cancer Management and Research. Volume 11. 9439–9448. 19 indexed citations
5.
Zhang, Lijuan, Xueqin Li, Cunde Wang, et al.. (2018). The Correlation of Visfatin and Its Gene Polymorphism with Non-Small Cell Lung Cancer. Cancer Biotherapy and Radiopharmaceuticals. 33(10). 460–465. 4 indexed citations
6.
Liu, Xin, Gang Luo, Yunfeng Li, et al.. (2016). Acquired resistance to HSP90 inhibitor 17-AAG and increased metastatic potential are associated with MUC1 expression in colon carcinoma cells. Anti-Cancer Drugs. 27(5). 417–426. 6 indexed citations
7.
Ren, Xuequn, Wan‐Li Ma, Hong Lu, et al.. (2015). Modification of cytokine-induced killer cells with chimeric antigen receptors (CARs) enhances antitumor immunity to epidermal growth factor receptor (EGFR)-positive malignancies. Cancer Immunology Immunotherapy. 64(12). 1517–1529. 19 indexed citations
8.
Zhou, Yongchun, Xicai Wang, Yunchao Huang, et al.. (2015). Down‐regulated SOX4 Expression Suppresses Cell Proliferation, Metastasis and Induces Apoptosis in Xuanwei Female Lung Cancer Patients. Journal of Cellular Biochemistry. 116(6). 1007–1018. 33 indexed citations
9.
Li, Jia, Yeying Wang, Xiaoqun Chen, et al.. (2014). Impact of Cellular Immune Function on Prognosis of Lung Cancer Patients after Cytokine-induced Killer Cell Therapy. Asian Pacific Journal of Cancer Prevention. 15(15). 6009–6014. 11 indexed citations
10.
Zhou, Yongchun, Xicai Wang, Lianhua Ye, et al.. (2014). MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB. Cancer Letters. 347(1). 65–74. 89 indexed citations
11.
Chen, Xiaoqun, et al.. (2013). Moderating Effects and Maintenance of Lung Cancer Cellular Immune Functions by CIK Cell Therapy. Asian Pacific Journal of Cancer Prevention. 14(6). 3587–3592. 13 indexed citations
12.
Wang, Xicai, Yan Chen, Jiying Wang, et al.. (2012). Thyroid transcription factor 1 represses the expression of Ki-67 and induces apoptosis in non-small cell lung cancer. Oncology Reports. 28(5). 1544–1550. 19 indexed citations
13.
Ren, Shunxiang, Shuguang Zuo, Minyi Zhao, et al.. (2011). Inhibition of tumor angiogenesis in lung cancer by T4 phage surface displaying mVEGFR2 vaccine. Vaccine. 29(34). 5802–5811. 30 indexed citations
14.
Wang, Xicai. (2011). Advances of experimental research in anti-lung cancer by traditional Chinese medicine. 1 indexed citations
15.
Wang, Xicai, et al.. (2010). Experimental study on anti-colorectal cancer efficacy of extracts of TCM Compound AK combined with cisplatin. Zhonghua zhongyiyao zazhi. 25(10). 1666–1669. 1 indexed citations
16.
Huo, Longfei, et al.. (2010). Inhibition of Melanoma Growth by Subcutaneous Administration of hTERTC27 Viral Cocktail in C57BL/6 Mice. PLoS ONE. 5(9). e12705–e12705. 18 indexed citations
17.
Wang, Xicai. (2008). Investigation of the Immunity-enhancement Capability of the Acer Capsule in Mice. 2 indexed citations
18.
Wang, Xicai. (2007). Anti-tumor Effect of Artemether in CT-26 Colorectal Cancer Bearing BALB/c Mice. 2 indexed citations
19.
Wang, Xicai, et al.. (2006). An Experimental Study of Traditional Chinese Medicine Kangfuxin Inducing Apoptosis In Vitro of Peptic Carcinoma Cell Line BGC-823. 2 indexed citations
20.
Lü, Gang, et al.. (2005). <I>bcl2, bax,</I> and <I>nestin</I> in the Brains of Patients With Neurodegeneration and Those of Normal Aging. Journal of Molecular Neuroscience. 27(2). 167–174. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026